Works by Kay, Jonathan


Results: 91
    1
    2
    3
    4

    Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.

    Published in:
    Rheumatology, 2022, v. 61, n. 4, p. 1385, doi. 10.1093/rheumatology/keab460
    By:
    • Furst, Daniel E;
    • Jaworski, Janusz;
    • Wojciechowski, Rafal;
    • Wiland, Piotr;
    • Dudek, Anna;
    • Krogulec, Marek;
    • Jeka, Slawomir;
    • Zielinska, Agnieszka;
    • Trefler, Jakub;
    • Bartnicka-Maslowska, Katarzyna;
    • Krajewska-Wlodarczyk, Magdalena;
    • Klimiuk, Piotr A;
    • Lee, Sang Joon;
    • Kim, Sung Hyun;
    • Bae, Yun Ju;
    • Yang, Go Eun;
    • Yoo, Jae Kyoung;
    • Kay, Jonathan;
    • Keystone, Edward
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

    Published in:
    Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01644-3
    By:
    • Buhigas, Claudia;
    • Warren, Anne Y.;
    • Leung, Wing-Kit;
    • Whitaker, Hayley C.;
    • Luxton, Hayley J.;
    • Hawkins, Steve;
    • Kay, Jonathan;
    • Butler, Adam;
    • Xu, Yaobo;
    • Woodcock, Dan J.;
    • Merson, Sue;
    • Frame, Fiona M.;
    • Sahli, Atef;
    • Abascal, Federico;
    • CRUK-ICGC Prostate Cancer Group;
    • Gihawi, Abraham;
    • Lambert, Adam;
    • Thompson, Alan;
    • Futreal, Andrew;
    • Menzies, Andrew
    Publication type:
    Article
    12

    Role of perfusion imaging in diagnosing myxoma mimics.

    Published in:
    European Heart Journal - Cardiovascular Imaging, 2016, v. 17, n. 2, p. 216, doi. 10.1093/ehjci/jev300
    By:
    • Yazdani, Momina Fatima;
    • Dajun Wan;
    • Ammar, Khawaja Afzal;
    • Kay, Jonathan;
    • Kress, David C.
    Publication type:
    Article
    13

    Communicating with clinicians.

    Published in:
    Annals of Clinical Biochemistry, 2001, v. 38, n. 2, p. 103, doi. 10.1258/0004563011900380
    By:
    • Kay, Jonathan D. S.
    Publication type:
    Article
    14
    15

    Corrigendum: Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

    Published in:
    Nature Genetics, 2015, v. 47, n. 6, p. 689, doi. 10.1038/ng0615-689b
    By:
    • Cooper, Colin S;
    • Eeles, Rosalind;
    • Wedge, David C;
    • Van Loo, Peter;
    • Gundem, Gunes;
    • Alexandrov, Ludmil B;
    • Kremeyer, Barbara;
    • Butler, Adam;
    • Lynch, Andrew G;
    • Camacho, Niedzica;
    • Massie, Charlie E;
    • Kay, Jonathan;
    • Luxton, Hayley J;
    • Edwards, Sandra;
    • Kote-Jarai, Zsofia;
    • Dennis, Nening;
    • Merson, Sue;
    • Leongamornlert, Daniel;
    • Zamora, Jorge;
    • Corbishley, Cathy
    Publication type:
    Article
    16
    17
    18
    19

    Reply.

    Published in:
    2018
    By:
    • Gravallese, Ellen M.;
    • Kay, Jonathan;
    • Duryea, Jeffrey;
    • Solomon, Daniel H.
    Publication type:
    Letter to the Editor
    20

    The Science Behind Biosimilars.

    Published in:
    Arthritis & Rheumatology, 2018, v. 70, n. 3, p. 334, doi. 10.1002/art.40388
    By:
    • Bridges, Jr., S. Louis;
    • White, Douglas W.;
    • Worthing, Angus B.;
    • Gravallese, Ellen M.;
    • O'Dell, James R.;
    • Nola, Kamala;
    • Kay, Jonathan;
    • Cohen, Stanley B.;
    • on behalf of the American College of Rheumatology
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    Book Review.

    Published in:
    Amyloid, 1996, v. 3, n. 4, p. 294, doi. 10.3109/13506129609014377
    By:
    • Kay, Jonathan
    Publication type:
    Article
    29

    Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates.

    Published in:
    Prostate, 2018, v. 78, n. 16, p. 1229, doi. 10.1002/pros.23698
    By:
    • Olivier, Jonathan;
    • Stavrinides, Vasilis;
    • Kay, Jonathan;
    • Freeman, Alex;
    • Pye, Hayley;
    • Ahmed, Zeba;
    • Carmona Echeverria, Lina;
    • Heavey, Susan;
    • Simmons, Lucy A. M.;
    • Kanthabalan, Abi;
    • Arya, Manit;
    • Briggs, Tim;
    • Barratt, Dean;
    • Charman, Susan C.;
    • Gelister, James;
    • Hawkes, David;
    • Hu, Yipeng;
    • Jameson, Charles;
    • McCartan, Neil;
    • Punwani, Shonit
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.

    Published in:
    Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02394-7
    By:
    • Kay, Jonathan;
    • Jaworski, Janusz;
    • Wojciechowski, Rafal;
    • Wiland, Piotr;
    • Dudek, Anna;
    • Krogulec, Marek;
    • Jeka, Slawomir;
    • Zielinska, Agnieszka;
    • Trefler, Jakub;
    • Bartnicka-Maslowska, Katarzyna;
    • Krajewska-Wlodarczyk, Magdalena;
    • Klimiuk, Piotr A.;
    • Lee, Sang Joon;
    • Bae, Yun Ju;
    • Yang, Go Eun;
    • Yoo, Jae Kyoung;
    • Furst, Daniel E.;
    • Keystone, Edward
    Publication type:
    Article
    38

    Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study.

    Published in:
    Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0516-6
    By:
    • Smolen, Josef S.;
    • Kay, Jonathan;
    • Doyle, Mittie;
    • Landewé, Robert;
    • Matteson, Eric L.;
    • Gaylis, Norman;
    • Wollenhaupt, Jürgen;
    • Murphy, Frederick T.;
    • Xu, Stephen;
    • Yiying Zhou;
    • Hsia, Elizabeth C.
    Publication type:
    Article
    39

    Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study.

    Published in:
    Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 61, doi. 10.1186/s13075-015-0516-6
    By:
    • Smolen, Josef S.;
    • Kay, Jonathan;
    • Doyle, Mittie;
    • Landewé, Robert;
    • Matteson, Eric L.;
    • Gaylis, Norman;
    • Wollenhaupt, Jürgen;
    • Murphy, Frederick T.;
    • Xu, Stephen;
    • Yiying Zhou;
    • Hsia, Elizabeth C.
    Publication type:
    Article
    40
    41
    42

    Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.

    Published in:
    CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1280, doi. 10.1111/cts.12967
    By:
    • Yu, Kyung‐Sang;
    • Jang, In‐Jin;
    • Lim, Hyeong‐Seok;
    • Hong, Jang Hee;
    • Kim, Min‐Gul;
    • Park, Min Kyu;
    • Cho, Doo‐Yeoun;
    • Park, Min Soo;
    • Chung, Jae Yong;
    • Ghim, Jong‐Lyul;
    • Lee, SeungHwan;
    • Yoon, Seok Kyu;
    • Kwon, In Sun;
    • Lee, Sang Joon;
    • Kim, Sung Hyun;
    • Bae, Yun Ju;
    • Cha, Jung Bin;
    • Furst, Daniel E.;
    • Keystone, Edward;
    • Kay, Jonathan
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50